Yumei Cao

机构：Nanjing General Hospital of Nanjing Military Command, Kanion Pharmaceutical (China), Guangzhou Vocational College of Science and Technology, Weifang People's Hospital, Zhujiang Hospital, University of Kansas Medical Center, Southern Medical University · ORCID：0000-0002-0914-4145

发表论文 143 篇 · 总被引 7541 次 · h-index 42

代表论文

• Single-cell atlas of human infrapatellar fat pad and synovium implicates APOE signaling in osteoarthritis pathology (2024 · Science Translational Medicine · 被引 142)
• Circular RNA circNFKB1 promotes osteoarthritis progression through interacting with ENO1 and sustaining NF-κB signaling (2022 · Cell Death and Disease · 被引 53)
• Hierarchical functional nanoparticles boost osteoarthritis therapy by utilizing joint-resident mesenchymal stem cells (2022 · Journal of Nanobiotechnology · 被引 50)
• The lncRNA PILA promotes NF-κB signaling in osteoarthritis by stimulating the activity of the protein arginine methyltransferase PRMT1 (2022 · Science Signaling · 被引 41)
• Carboxymethyl chitosan-assisted MnOx nanoparticles: Synthesis, characterization, detection and cartilage repair in early osteoarthritis (2022 · Carbohydrate Polymers · 被引 38)
• Extracellular Vesicles in Infrapatellar Fat Pad from Osteoarthritis Patients Impair Cartilage Metabolism and Induce Senescence (2023 · Advanced Science · 被引 31)